These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 27096405)

  • 1. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of refracture associated with compliance and persistence with bisphosphonate therapy in Taiwan.
    Soong YK; Tsai KS; Huang HY; Yang RS; Chen JF; Wu PC; Huang KE
    Osteoporos Int; 2013 Feb; 24(2):511-21. PubMed ID: 22588182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate Use and the Risk of Undergoing Total Knee Arthroplasty in Osteoporotic Patients with Osteoarthritis: A Nationwide Cohort Study in Taiwan.
    Fu SH; Wang CY; Yang RS; Wu FL; Hsiao FY
    J Bone Joint Surg Am; 2017 Jun; 99(11):938-946. PubMed ID: 28590379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study.
    Sahota O; Narayanasamy M; Bastounis A; Paskins Z; Bishop S; Langley T; Gittoes N; Davis S; Baily A; Holmes M; Leonardi-Bee J
    Health Technol Assess; 2024 Apr; 28(21):1-169. PubMed ID: 38634483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate use after clinical fracture and risk of new fracture.
    Bergman J; Nordström A; Nordström P
    Osteoporos Int; 2018 Apr; 29(4):937-945. PubMed ID: 29397408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
    Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
    N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Mignot MA; Taisne N; Legroux I; Cortet B; Paccou J
    Osteoporos Int; 2017 Dec; 28(12):3431-3438. PubMed ID: 28875236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for fracture among current, persistent users of bisphosphonates.
    LeBlanc ES; Rosales AG; Balasubramanian A; O'Malley CD; Egbuna O; Friess D; Perrin NA
    Osteoporos Int; 2015 Feb; 26(2):713-25. PubMed ID: 25354654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review.
    Fink HA; MacDonald R; Forte ML; Rosebush CE; Ensrud KE; Schousboe JT; Nelson VA; Ullman K; Butler M; Olson CM; Taylor BC; Brasure M; Wilt TJ
    Ann Intern Med; 2019 Jul; 171(1):37-50. PubMed ID: 31009947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry.
    Khatod M; Inacio MC; Dell RM; Bini SA; Paxton EW; Namba RS
    Clin Orthop Relat Res; 2015 Nov; 473(11):3412-20. PubMed ID: 25896134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.
    Drieling RL; LaCroix AZ; Beresford SAA; Boudreau DM; Kooperberg C; Chlebowski RT; Ko MG; Heckbert SR
    J Am Geriatr Soc; 2017 Sep; 65(9):1924-1931. PubMed ID: 28555811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.
    Wang Z; Ward MM; Chan L; Bhattacharyya T
    Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data.
    Shalev V; Sharman Moser S; Goldshtein I; Yu J; Weil C; Ish-Shalom S; Rouach V; Chodick G
    Ann Pharmacother; 2017 Sep; 51(9):757-767. PubMed ID: 28535690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.
    McHorney CA; Schousboe JT; Cline RR; Weiss TW
    Curr Med Res Opin; 2007 Dec; 23(12):3137-52. PubMed ID: 17988435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based 2-year follow-up study on the relationship between bisphosphonates and the risk of stroke.
    Kang JH; Keller JJ; Lin HC
    Osteoporos Int; 2012 Oct; 23(10):2551-7. PubMed ID: 22270858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Ha KY; Park KS; Kim SI; Kim YH
    Osteoporos Int; 2016 Feb; 27(2):483-8. PubMed ID: 26202489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between bisphosphonate use and non-union of fractures of the humerus in older adults.
    Solomon DH; Hochberg MC; Mogun H; Schneeweiss S
    Osteoporos Int; 2009 Jun; 20(6):895-901. PubMed ID: 18843515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of osteoporosis treatment patterns with bisphosphonates and outcomes among postmenopausal veterans.
    LaFleur J; DuVall SL; Willson T; Ginter T; Patterson O; Cheng Y; Knippenberg K; Haroldsen C; Adler RA; Curtis JR; Agodoa I; Nelson RE
    Bone; 2015 Sep; 78():174-85. PubMed ID: 25896952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.